Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
PBYI current report impresive 7th august
85billions
Oops!
Now what Charlie??
LOL
Puma
Days later i coment this event
Exelon will buy this week PUMA BIO
the informaticon is top secret.
If you need fast money you must buy puma no more!!!
Today gapper candidate
EXELON could pay 965Billion dolars in cash for PBYI.This point is confuse but pay in cash is sure.
Congrats at alls
EXELON could buy PUMA BIOTEC.in cash
Morgan Stanley is assesor Source DBANK in Germany
Yea man loved watching him fight. Good ole days
Greatest Fighting Quote Ever...
hi...DC or Derrick Lewis?
Edit: meant down another 48% today!
down another 20% this morning,isn't this an overreaction on PBYI?
Oucher -52% seen it falling since 100s after earnings for whole year
Credit Suisse Group Boosts Puma Biotechnology Inc (PBYI) Price Target to $142.00
November 10th, 2017 •
Puma Biotechnology logoPuma Biotechnology Inc (NYSE:PBYI) had its price objective lifted by equities researchers at Credit Suisse Group from $136.00 to $142.00 in a research report issued to clients and investors on Friday. The brokerage currently has an “outperform” rating on the biopharmaceutical company’s stock. Credit Suisse Group’s target price would indicate a potential upside of 37.86% from the stock’s previous close.
PBYI Jul-10-17 Resumed Leerink Partners Outperform $115
good analyst call= $$$
LET'S..SEE..HOW..HIGH..PBYI..FLIES..TOMORROW.
Partner Fund Management, L.P. has filed a new 13G, reporting 8.0% ownership in $PBYI - https://fintel.io/so/us/pbyi and https://fintel.io/i/partner-fund-management
Meeting notes stated drug is only for 80% of women who previously had breast cancer. so does this hit $100 this year?
Its about to get super wild here.. $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
excuse me. I meant 70+ lol
Got approval from the meeting!
Yes: 12
No: 4
Be on watch for unhalt!
https://stocknews.com/news/pbyi-oncologic-drugs-advisory-committee-meeting-committee-votes-124-in-favor/
Puma Biotechnology who NASDAQ ticker symbol is PBYI, was one of the highest performers on Monday's trading session. PBYI's shares soared on investor's anticipation that the FDA will approve its neratinib breast cancer drug. The FDA is scheduled to meet on this matter later in the week and is reviewing approvability of the cancer drug. At one point the stock was up 84% but sold off throughout the day still closing at 39.15% gain from its open.
This type of price action is Day Trader nirvana. The stock made multiple moves throughout its trading day. Within the first 30 minutes of trading the stock broke its opening range which led to being halted on the NASDAQ. With only a 31.82M float the stock post halt moved from $47.23 to $69.35 in a matter of 15 minutes. This short squeeze is correlated to the 25% in short float as many investors have had a lack of confidence in Puma's ability to get FDA approval. When the stock couldn't hold its gains its trend changed to the downside south of $65 before finding support around the $50 range. There was opportunity to go long in the early hours of the trading day as well as better opportunities to short PBYI in the afternoon.
From Seeking Alpha
PBYI Halted Squeezed And Shorted
Yes, Looking Good, also FINVIZ says Target of $72.50 and The 05-22 News on FINVIZ if you read it says Meeting on the 24th Likely to approve. Tomorrow might be a very up day. Looking forward to it.
Price Target Lowered to $17.00 at RBC Capital Markets
https://www.chaffeybreeze.com/2017/03/08/puma-biotechnology-inc-pbyi-price-target-lowered-to-17-00-at-rbc-capital-markets.html
They running out of cash by mid year looks like a great Short opportunity here
Here’s Why The Puma Biotechnology Pullback Might Be A Buy-In Opportunity http://marketexclusive.com/heres-puma-biotechnology-inc-nysepbyi-pullback-might-buy-opportunity/37072/?icd1
Isn't it crazy? How we are at $.18 and they are at $50...
$PBYI secondary here as they fight Fred Eschelman is asanine crazy, and against the interest of stockholders. In addition, Susan Li is hot
$PBYI plans to submit a European approval application for immodium for the treatment of insane-grade diarrhea caused by neratinib.
I wondered the same thing. Puma does not have any revenue correct? How did PPS appreciate to such high levels?
Santa's helpers like JUNO.
$PBYI Cowen Remains Positive On Puma Biotechnology In Light Of NDA Submission Delay http://www.smarteranalyst.com/2014/12/03/cowen-remains-positive-on-puma-biotechnology-in-light-of-nda-submission-delay/
Shed a bag. Switch filing to double potential for faithful longs BS noise to follow. Ambulance chasers are swarming.
Just like $SN*S expect a giant gap down.
$PBYI
Haha they didn't even have the courtesy of dropping this bombshell news during the day, the market is so rigged what a POS company.
$PBYI
If you like how Puma has grown from its inception, another cancer fighting company similar to Puma's end goals is Theralase (V.TLT on TSX or TLTFF in US). They're focusing on bladder cancer. Give it a look sometime.
$PBYI DD Notes ~ http://www.ddnotesmaker.com/PBYI
bullish long term
$PBYI recent news/filings
## source: finance.yahoo.com
Wed, 22 Oct 2014 22:09:30 GMT ~ NYSE stocks posting largest volume increases
[AP] - A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading: China Green Agriculture Inc. : Approximately 13,288,500 shares changed hands, a 6,591.2 percent increase over ...
read full: http://sg.finance.yahoo.com/news/nyse-stocks-posting-largest-volume-220412869--finance.html
*********************************************************
Fri, 10 Oct 2014 11:00:00 GMT ~ Biotech Stock Mailbag: Keryx, Puma, Gilead, Arrowhead and Hate Mail Galore!
read full: http://www.thestreet.com/story/12908531/1/biotech-stock-mailbag-keryx-puma-gilead-arrowhead-and-hate-mail-galore.html?puc=yahoo&cm_ven=YAHOO
*********************************************************
Sat, 04 Oct 2014 04:01:00 GMT ~ [$$] A Poor Quarter for U.S. Equity Funds
read full: http://online.barrons.com/article/SB51517841841143733463604580184362766342610.html?mod=yahoobarrons&ru=yahoo
*********************************************************
Mon, 29 Sep 2014 20:34:17 GMT ~ PUMA BIOTECHNOLOGY, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
read full: http://biz.yahoo.com/e/140929/pbyi8-k.html
*********************************************************
Mon, 29 Sep 2014 15:14:25 GMT ~ Cancer drug stocks on the move amid striking data
read full: http://www.cnbc.com/id/102040769?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=102040769
*********************************************************
$PBYI charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$PBYI company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/PBYI/company-info
Ticker: $PBYI
OTC Market Place: Not Available
CIK code: 0001401667
Company name: Puma Biotechnology Inc.
Company website: http://www.pumabiotechnology.com
Incorporated In: DE, USA
Business Description:
$PBYI share structure
## source: otcmarkets.com
Market Value: $7,259,900,270 a/o Oct 24, 2014
Shares Outstanding: 30,117,819 a/o Feb 28, 2014
Float: Not Available
Authorized Shares: 100,000,000 a/o Dec 31, 2011
Par Value: 0.0001
$PBYI extra dd links
Company name: Puma Biotechnology Inc.
Company website: http://www.pumabiotechnology.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/PBYI/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/PBYI/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=PBYI+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=PBYI+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=PBYI+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/PBYI/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/PBYI/news - http://finance.yahoo.com/q/h?s=PBYI+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/PBYI/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/PBYI/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/PBYI/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/PBYI/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/PBYI/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/PBYI/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/PBYI/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/PBYI/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=PBYI+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/PBYI
DTCC (dtcc.com): http://search2.dtcc.com/?q=Puma+Biotechnology+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Puma+Biotechnology+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Puma+Biotechnology+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.pumabiotechnology.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.pumabiotechnology.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.pumabiotechnology.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/PBYI/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/PBYI
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/PBYI/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/PBYI/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/PBYI/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001401667&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/PBYI/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/PBYI/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/PBYI/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/PBYI/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=PBYI&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=PBYI
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/PBYI/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=PBYI+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=PBYI+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=PBYI
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=PBYI
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=PBYI+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/PBYI/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=PBYI+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/PBYI.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=PBYI
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/PBYI/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/PBYI/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/PBYI/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/PBYI/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/PBYI
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/PBYI
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/PBYI:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=PBYI
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=PBYI
$PBYI DD Notes ~ http://www.ddnotesmaker.com/PBYI
If $PBYI breaks under $200 there may be something wrong that we don't know about.
If it breaks under $190...........it could be toast!
Followers
|
21
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
179
|
Created
|
10/19/12
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |